Pharmacologist Shares Insight on Cancer Drug Shortage
Pharmacology expert聽,听associate professor at NYITCOM, is quoted in聽聽and聽other news sites regarding a monthslong shortage of the chemotherapy drugs carboplatin and cisplatin. The low inventories of these drugs, which are viewed as “mainstays” in cancer therapy, are causing hospitals and healthcare systems across the country to ration the products and postpone necessary, lifesaving treatments.聽Pino explains that the shortage is impacting a variety of cancer patients, as cisplatin is used to manage and treat many solid tumors, including gynecological, testicular, and lung cancers, as well as hematologic (blood) malignancies, while carboplatin is often used to manage ovarian cancer.
鈥淐arboplatin and cisplatin remain the 鈥榗lassical drugs鈥� in the treatment of cancer. This shortage can delay treatment, increasing psychological anxiety to the patient, family, and all those involved in the patient鈥檚 care,鈥� Pino tells The Ritz Herald.